Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec;42(4):385-396.
doi: 10.23736/S0391-1977.16.02514-1. Epub 2016 Sep 14.

Ruminant trans-fatty acids and risk of breast cancer: a systematic review and meta-analysis of observational studies

Roya Kolahdouz Mohammadi  1   2 , Minoo Bagheri  3 , Mina Kolahdouz Mohammadi  1   4 , Farzad Shidfar  5   2
Affiliations
Review

Ruminant trans-fatty acids and risk of breast cancer: a systematic review and meta-analysis of observational studies

Roya Kolahdouz Mohammadi et al. Minerva Endocrinol. 2017 Dec.

Abstract

Introduction: Ruminant trans-fatty acids, especially cis9, trans11-conjugated linoleic acid (c9,t11-CLA) and trans11-18:1 vaccenic acid (t11-18:1 VA) appear to have anticarcinogenic activity against breast cancer in animal and in vitro experiments. However, the results remain inconsistent. We therefore conducted a systematic review and meta-analysis to assess the association of c9,t11-CLA, and t11-18:1 VA (intake or serum levels) with breast cancer risk.

Evidence acquisition: Relevant studies were identified by a search of PubMed, OVID, SCOPUS and Google scholar databases through 25 May 2015. We included case-control and cohort studies that reported relative risk (RR) estimates with 95% confidence intervals (CIs) for the association between c9,t11-CLA and t11-18:1 VA intake or their serum levels and the risk of breast cancer. This meta-analysis was conducted according to the guidelines for the meta-analysis of observational studies in epidemiology.

Evidence synthesis: Three studies on c9,t11-CLA and t11-18:1 VA serum levels and t11-18:1 VA intake were evaluated in the systematic review only (narrative synthesis) and four studies (2 case-control and 2 cohort studies on c9,t11-CLA intake) were included in the meta-analysis (quantitative synthesis). The pooled RR for the highest vs lowest category of c9,t11-CLA intake was 0.94 (95% CI: 0.64-1.25) with evidence of heterogeneity (with 67,533 participants, I2=78.3%, P=0.003). Studies that could not be included in the quantitative syntheses were inconclusive.

Conclusions: No association was found between c9,t11-CLA intake and breast cancer risk, but the number of studies identified was small.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

Substances